Showing results (111-120 of 118) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Transplantation and Cellular Therapy|March 1, 2026
Landmark-Based Evaluations of Long-Term Outcomes After CD19 CAR T-cell Therapy in Large B-Cell LymphomaMarina Gomez-Llobell, Roni Shouval, Samantha Brown, et al.Blood|January 12, 2017
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphomaReid W Merryman, Haesook T Kim, Pier Luigi Zinzani, et al.Communications Medicine|October 25, 2023
Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patientsJunichiro Yuda, Christine Will, Darren C Phillips, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2018
Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 TrialAndrea Gallamini, Corrado Tarella, Simonetta Viviani, et al.Leukemia|November 6, 2022
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphomaAna Alarcon Tomas, Joshua A Fein, Shalev Fried, et al.Blood|April 21, 2025
T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell TherapyKai Rejeski, Jaime Sanz, Teng Fei, et al.Blood|January 5, 2026
Time of Day of CAR T-Cell Infusion and Outcomes in Large B-Cell LymphomaDanny Luan, Ori Ben Valid, Ofrat Beyar-Katz, et al.Nature Medicine|April 1, 2025
An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphomaSandeep S Raj, Teng Fei, Shalev Fried, et al.Pageof 12